FMR CORP 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | Immunome, Inc. IMNM |
FMR CORP | 4,224,700 7.034% |
318,557 (+8.16%) |
Filing |
| 2024-02-09 09:16 am Purchase |
2024-02-08 | 13G | Immunome, Inc. IMNM |
FMR CORP | 3,906,143 9.141% |
3,906,143 (New Position) |
Filing |